GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Prestige Consumer Healthcare Inc (FRA:PBV) » Definitions » Cyclically Adjusted PS Ratio

Prestige Consumer Healthcare (FRA:PBV) Cyclically Adjusted PS Ratio : 2.90 (As of May. 22, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Prestige Consumer Healthcare Cyclically Adjusted PS Ratio?

As of today (2024-05-22), Prestige Consumer Healthcare's current share price is €59.50. Prestige Consumer Healthcare's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €20.54. Prestige Consumer Healthcare's Cyclically Adjusted PS Ratio for today is 2.90.

The historical rank and industry rank for Prestige Consumer Healthcare's Cyclically Adjusted PS Ratio or its related term are showing as below:

FRA:PBV' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 2.05   Med: 3.15   Max: 5.83
Current: 2.91

During the past years, Prestige Consumer Healthcare's highest Cyclically Adjusted PS Ratio was 5.83. The lowest was 2.05. And the median was 3.15.

FRA:PBV's Cyclically Adjusted PS Ratio is ranked worse than
61.56% of 744 companies
in the Drug Manufacturers industry
Industry Median: 2.135 vs FRA:PBV: 2.91

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Prestige Consumer Healthcare's adjusted revenue per share data for the three months ended in Mar. 2024 was €5.065. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €20.54 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Prestige Consumer Healthcare Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Prestige Consumer Healthcare's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prestige Consumer Healthcare Cyclically Adjusted PS Ratio Chart

Prestige Consumer Healthcare Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.43 2.66 2.77 3.02 3.26

Prestige Consumer Healthcare Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.02 2.81 2.66 2.83 3.26

Competitive Comparison of Prestige Consumer Healthcare's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Prestige Consumer Healthcare's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Prestige Consumer Healthcare's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Prestige Consumer Healthcare's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Prestige Consumer Healthcare's Cyclically Adjusted PS Ratio falls into.



Prestige Consumer Healthcare Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Prestige Consumer Healthcare's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=59.50/20.54
=2.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prestige Consumer Healthcare's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Prestige Consumer Healthcare's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=5.065/131.7762*131.7762
=5.065

Current CPI (Mar. 2024) = 131.7762.

Prestige Consumer Healthcare Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 2.041 100.560 2.675
201409 2.675 100.428 3.510
201412 3.039 99.070 4.042
201503 3.325 99.621 4.398
201506 3.233 100.684 4.231
201509 3.454 100.392 4.534
201512 3.454 99.792 4.561
201603 3.505 100.470 4.597
201606 3.527 101.688 4.571
201609 3.592 101.861 4.647
201612 3.851 101.863 4.982
201703 4.212 102.862 5.396
201706 4.268 103.349 5.442
201709 4.043 104.136 5.116
201712 4.271 104.011 5.411
201803 3.879 105.290 4.855
201806 4.107 106.317 5.090
201809 3.933 106.507 4.866
201812 4.065 105.998 5.054
201903 4.109 107.251 5.049
201906 3.948 108.070 4.814
201909 4.254 108.329 5.175
201912 4.277 108.420 5.198
202003 4.469 108.902 5.408
202006 4.009 108.767 4.857
202009 3.979 109.815 4.775
202012 3.882 109.897 4.655
202103 3.954 111.754 4.662
202106 4.409 114.631 5.068
202109 4.623 115.734 5.264
202112 4.769 117.630 5.343
202203 4.755 121.301 5.166
202206 5.167 125.017 5.446
202209 5.813 125.227 6.117
202212 5.183 125.222 5.454
202303 5.362 127.348 5.548
202306 5.136 128.729 5.258
202309 5.357 129.860 5.436
202312 5.173 129.419 5.267
202403 5.065 131.776 5.065

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Prestige Consumer Healthcare  (FRA:PBV) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Prestige Consumer Healthcare Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Prestige Consumer Healthcare's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Prestige Consumer Healthcare (FRA:PBV) Business Description

Traded in Other Exchanges
Address
660 White Plains Road, Tarrytown, NY, USA, 10591
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Prestige Consumer Healthcare (FRA:PBV) Headlines

No Headlines